Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.2 Rising incidence of pregnancy complications
3.2.3 Increase in childbirth rates
3.2.4 Growing awareness of induced labor and breastfeeding
3.2.5 Increasing research & development activities
3.2.6 Industry pitfalls & challenges
3.2.7 Stringent regulatory requirements
3.2.8 High cost of drug
3.3 Growth potential analysis
3.4 Pipeline analysis
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Antepartum
5.3 Postpartum
Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Online pharmacies
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Endo International plc
8.2 Ferring Pharmaceuticals
8.3 Fresenius SE & Co. KGaA
8.4 Hikma Pharmaceuticals PLC
8.5 Novartis AG
8.6 Pfizer Inc.
8.7 Sun Pharma Industries Limited.
8.8 Teva Pharmaceutical Industries Ltd.
8.9 Viatris Inc.
8.10 Wockhardt Limited
8.11 Yuhan Corporation
